Torafix

Torafix is a nonsteroidal anti-inflammatory drug (NSAID) marketed by Maks Drug Limited in Bangladesh. Its active ingredient is ketorolac tromethamine, a potent analgesic that works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for the synthesis of prostaglandins involved in pain and inflammation. Torafix is indicated for the short-term management of moderate to severe acute pain. It is available in multiple dosage forms, including 10 mg oral tablets and injectable formulations, providing flexibility for clinical administration in acute care settings.

Brand names

Torafix

Other names

ketorolac tromethamine